A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy
Authors:
- Marica GarzieraMGMarica Garziera
- Valli De ReValli De Re
- Silvano GeremiaSilvano Geremia
- Raquel SerucaRaquel Seruca
- Joana FigueiredoJoana Figueiredo
- Soraia MeloSMSoraia Melo
- Joana Simões-CorreiaJSJoana Simões-Correia
- Laura CaggiariLCLaura Caggiari
- Mariangela De ZorziMZMariangela De Zorzi
- Vincenzo CanzonieriVincenzo Canzonieri
- Renato CannizzaroRCRenato Cannizzaro
- Giuseppe ToffoliGTGiuseppe Toffoli
- 29 April 2012
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 13 (2) , 149-157
Abstract
It is well documented that germline mutations in the E-cadherin (CDH1) gene are linked to hereditary diffuse gastric cancer (HDGC). Despite the known molecular genetic causes, most gastric cancers are sporadic and poorly investigated for susceptibility genes. We report the finding of a novel germline missense mutation in exon 6, c. 820 G > A (p.G274S) in one sporadic gastric cancer patient. This new variant does not affect cryptic splicing of CDH1 as demonstrated by molecular assay. Immunohistochemical analysis shows a mixed pattern of E-cadherin staining (membranous and cytoplasmic) in the intestinal component, while in the diffuse counterpart, the membranous staining was prevalent and a reduced membranous expression of ß-catenin was observed. In vitro assays suggest that the mutant G274S does not affect the E-cadherin protein function, its expression pattern or subcellular localization. This new variant is present in EC2 extracellular domain of the protein (p.G120S in mature protein). The molecular modelling shows that this point mutation is not dramatic for local structure. However, p.S120 is located on the surface of the protein close to the functional calcium sites and in the region of interaction with EC1 domain of another E-cadherin molecule involved in the formation of the intercellular junction. Moreover, p.S120 residue could be involved in posttranslational modifications, such as phosphorylation or glycosylation, with possible effects on stability and integrity of adhesive properties of E-cadherin. In conclusion, the pathogenicity of this mutation is unlikely; probably we found a new germline CDH1 missense mutation with potential impact, however, of uncertain significance.Keywords
This publication has 24 references indexed in Scilit:
- Modulation of E-cadherin function and dysfunction by N-glycosylationCellular and Molecular Life Sciences, 2010
- Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future researchJournal of Medical Genetics, 2010
- E-cadherin immunoexpression patterns in the characterisation of gastric carcinoma histotypesJournal of Clinical Pathology, 2010
- The Crystal Structure of Human E-cadherin Domains 1 and 2, and Comparison with other Cadherins in the Context of Adhesion MechanismJournal of Molecular Biology, 2007
- Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric CancerJAMA, 2007
- Site-Directed Mutagenesis of Large (13-kb) Plasmids in a Single-PCR ProcedureBioTechniques, 2000
- E-cadherin germline mutations in familial gastric cancerNature, 1998
- Mutations of the human E-cadherin (CDH1) geneHuman Mutation, 1998
- Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survivalGastroenterology, 1997
- THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO‐CALLED INTESTINAL‐TYPE CARCINOMAActa Pathologica Microbiologica Scandinavica, 1965